Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Crescent Capital BDC (FCRX) Equity Average (2022 - 2025)

Historic Equity Average for Crescent Capital BDC (FCRX) over the last 4 years, with Q3 2025 value amounting to $719.4 million.

  • Crescent Capital BDC's Equity Average fell 416.03% to $719.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $719.4 million, marking a year-over-year decrease of 416.03%. This contributed to the annual value of $741.6 million for FY2024, which is 945.26% up from last year.
  • Per Crescent Capital BDC's latest filing, its Equity Average stood at $719.4 million for Q3 2025, which was down 416.03% from $725.9 million recorded in Q2 2025.
  • In the past 5 years, Crescent Capital BDC's Equity Average registered a high of $752.1 million during Q2 2024, and its lowest value of $617.6 million during Q4 2022.
  • Moreover, its 4-year median value for Equity Average was $725.9 million (2025), whereas its average is $705.0 million.
  • In the last 5 years, Crescent Capital BDC's Equity Average skyrocketed by 1924.61% in 2023 and then plummeted by 416.03% in 2025.
  • Over the past 4 years, Crescent Capital BDC's Equity Average (Quarter) stood at $617.6 million in 2022, then increased by 19.25% to $736.4 million in 2023, then rose by 1.13% to $744.7 million in 2024, then dropped by 3.4% to $719.4 million in 2025.
  • Its last three reported values are $719.4 million in Q3 2025, $725.9 million for Q2 2025, and $733.9 million during Q1 2025.